Sucampo Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sucampo Pharmaceuticals's estimated annual revenue is currently $9.4M per year.(i)
  • Sucampo Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Sucampo Pharmaceuticals has 47 Employees.(i)
  • Sucampo Pharmaceuticals grew their employee count by 0% last year.

Sucampo Pharmaceuticals's People

NameTitleEmail/Phone
1
Research and DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M35-3%N/AN/A
#2
$7.2M36-5%N/AN/A
#3
$10.5M52-9%N/AN/A
#4
$344.1M17129%N/AN/A
#5
$27.5M1376%N/AN/A
#6
$107.3M5349%N/AN/A
#7
$12.9M6428%N/AN/A
#8
$31.6M1571%N/AN/A
#9
$31.4M1567%N/AN/A
#10
$11.5M5730%N/AN/A
Add Company

What Is Sucampo Pharmaceuticals?

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sucampo Pharmaceuticals News

2022-04-20 - Irritable Bowel Syndrome with Constipation Drugs Market by ...

... some of the players studied are: Nestle , Abbot Laboratories , Synergy Pharmaceuticals , Sucampo Pharmaceuticals , Novartis , Astellas Pharmaceuticals.

2022-04-17 - Irritable Bowel Syndrome with Constipation Drugs Market Size ...

... Bowel Syndrome with Constipation Drugs Market Size 2022-2030| Key Players – Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals.

2022-04-17 - Retinitis Pigmentosa Treatment & Management Market Size ...

... Amarantus BioScience, Ocugen, ReGenX Biosciences, Sucampo Pharmaceuticals, Orphagen Pharmaceuticals, Okuvision, Second Sight Medical.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A474%N/A
#2
$8.8M470%$147.4M
#3
N/A482%N/A
#4
$8.1M489%N/A
#5
$10.4M4814%N/A